CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 129 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $94,000 | -47.8% | 5,789 | -41.2% | 0.00% | 0.0% |
| Q3 2019 | $180,000 | -6.2% | 9,845 | +10.1% | 0.00% | 0.0% |
| Q2 2019 | $192,000 | -37.3% | 8,945 | -42.7% | 0.00% | -66.7% |
| Q1 2019 | $306,000 | +45.0% | 15,602 | -4.3% | 0.00% | +50.0% |
| Q4 2018 | $211,000 | -49.4% | 16,297 | -6.7% | 0.00% | -50.0% |
| Q3 2018 | $417,000 | +50.0% | 17,467 | +20.3% | 0.00% | 0.0% |
| Q2 2018 | $278,000 | +72.7% | 14,519 | +11.9% | 0.00% | +100.0% |
| Q1 2018 | $161,000 | +96.3% | 12,976 | +91.2% | 0.00% | +100.0% |
| Q4 2017 | $82,000 | -24.8% | 6,786 | -14.4% | 0.00% | -50.0% |
| Q3 2017 | $109,000 | +12.4% | 7,931 | +25.3% | 0.00% | 0.0% |
| Q2 2017 | $97,000 | -7.6% | 6,330 | +10.3% | 0.00% | 0.0% |
| Q1 2017 | $105,000 | +337.5% | 5,741 | +125.2% | 0.00% | +100.0% |
| Q4 2016 | $24,000 | – | 2,549 | +5564.4% | 0.00% | – |
| Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
| Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
| Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
| DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
| Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
| DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
| B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |